• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation.

作者信息

Hoff H F, Hoppe G

机构信息

Department of Cell Biology, Research Institute of the Cleveland Clinic Foundation, Ohio, USA.

出版信息

Curr Opin Lipidol. 1995 Oct;6(5):317-25. doi: 10.1097/00041433-199510000-00012.

DOI:10.1097/00041433-199510000-00012
PMID:8520855
Abstract

Structural and chemical modifications of plasma lipoproteins retained in atherosclerotic lesions, especially LDL, are a characteristic of atherogenesis. The major cholesterol-containing structures believed to be derived primarily from LDL are monomeric or aggregated native or modified LDL particles, cholesteryl ester droplets, liposomes rich in unesterified cholesterol, and ceroid-lipofuscin. They are suggested to be formed primarily from LDL by combinations of oxidation, hydrolysis by proteases and esterases, fusion of neutral lipid components, and covalent interactions between lipid and protein components of oxidized LDL in lysosomes. Although many of these structures appear to be refractory to removal by reverse cholesterol transport mechanisms, they may possess functional properties that still need to be elucidated.

摘要

相似文献

1
Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation.
Curr Opin Lipidol. 1995 Oct;6(5):317-25. doi: 10.1097/00041433-199510000-00012.
2
Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions.
J Lipid Res. 2000 Nov;41(11):1703-14.
3
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux.脂蛋白(a)与氧化型低密度脂蛋白的致动脉粥样硬化性:来自动脉壁内流、降解和外流体内研究的见解
Atherosclerosis. 1999 Apr;143(2):229-43. doi: 10.1016/s0021-9150(99)00064-7.
4
Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome.
J Biol Chem. 1992 Mar 5;267(7):4992-8.
5
Evidence for loss of apo B from LDL in human atherosclerotic lesions: extracellular cholesteryl ester lipid particles lacking apo B.
Atherosclerosis. 1994 Feb;105(2):227-34. doi: 10.1016/0021-9150(94)90053-1.
6
Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.低密度脂蛋白的氧化修饰增加其与人主动脉内膜细胞外基质的结合:病变发展、脂蛋白脂肪酶和钙的影响。
J Pathol. 2001 Sep;195(2):244-50. doi: 10.1002/path.935.
7
Evaluation of oxidized low-density lipoprotein and large molecular size low-density lipoproteins in atherosclerosis.动脉粥样硬化中氧化型低密度脂蛋白和大分子大小低密度脂蛋白的评估
Pathobiology. 1993;61(3-4):200-10. doi: 10.1159/000163794.
8
Lipoprotein cholesterol and atherosclerosis.脂蛋白胆固醇与动脉粥样硬化。
Curr Mol Med. 2001 Dec;1(6):633-53. doi: 10.2174/1566524013363212.
9
[Cholesterol metabolism in the arteriosclerotic intima].[动脉粥样硬化内膜中的胆固醇代谢]
Zentralbl Allg Pathol. 1989;135(6):505-9.
10
Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.早期动脉粥样硬化形成过程中巨噬细胞泡沫细胞的形成取决于动脉细胞和血液脂蛋白中促氧化剂与抗氧化剂之间的平衡。
Antioxid Redox Signal. 1999 Winter;1(4):585-94. doi: 10.1089/ars.1999.1.4-585.

引用本文的文献

1
Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis.溶酶体在动脉粥样硬化中免疫细胞的免疫代谢重编程过程中的作用
Nat Rev Cardiol. 2025 Mar;22(3):149-164. doi: 10.1038/s41569-024-01072-4. Epub 2024 Sep 20.
2
Lysosome (Dys)function in Atherosclerosis-A Big Weight on the Shoulders of a Small Organelle.溶酶体(功能异常)在动脉粥样硬化中的作用——小细胞器肩负重任
Front Cell Dev Biol. 2021 Mar 29;9:658995. doi: 10.3389/fcell.2021.658995. eCollection 2021.
3
ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker.
载脂蛋白B-100与内膜蛋白聚糖形成脂蛋白复合物作为动脉粥样硬化的病因及其作为疾病生物标志物的体外评估可能性
J Cardiovasc Dev Dis. 2018 Jul 1;5(3):36. doi: 10.3390/jcdd5030036.
4
Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism.溶酶体酸性脂肪酶:在正常和动脉粥样硬化胆固醇代谢的十字路口。
Front Cell Dev Biol. 2015 Feb 2;3:3. doi: 10.3389/fcell.2015.00003. eCollection 2015.
5
Lysosomes, cholesterol and atherosclerosis.溶酶体、胆固醇与动脉粥样硬化
Clin Lipidol. 2010 Dec 1;5(6):853-865. doi: 10.2217/clp.10.70.